Cg Oncology Inc [CGON] stock prices are up 9.36% to $19.28 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The CGON shares have gain 12.09% over the last week, with a monthly amount drifted -25.70%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, UBS started tracking the stock with Buy rating on October 24, 2024, and set its price target to $60. On September 23, 2024, RBC Capital Mkts initiated with a Outperform rating and assigned a price target of $66 on the stock. ROTH MKM started tracking the stock assigning a Buy rating and suggested a price target of $65 on August 28, 2024. BofA Securities initiated its recommendation with a Buy and recommended $65 as its price target on June 28, 2024. Morgan Stanley started tracking with a Overweight rating for this stock on February 20, 2024, and assigned it a price target of $55. In a note dated February 20, 2024, Goldman initiated an Neutral rating and provided a target price of $42 on this stock.
The stock price of Cg Oncology Inc [CGON] has been fluctuating between $14.80 and $46.99 over the past year. Currently, Wall Street analysts expect the stock to reach $57.5 within the next 12 months. Cg Oncology Inc [NASDAQ: CGON] shares were valued at $19.28 at the most recent close of the market. An investor can expect a potential return of 198.24% based on the average CGON price forecast.
Analyzing the CGON fundamentals
The Cg Oncology Inc [NASDAQ:CGON] reported sales of 1.14M for trailing twelve months, representing a surge of 45500.00%. Gross Profit Margin for this corporation currently stands at 0.99% with Operating Profit Margin at -100.67%, Pretax Profit Margin comes in at -77.29%, and Net Profit Margin reading is -77.29%. To continue investigating profitability, this company’s Return on Assets is posted at -0.12, Equity is -0.15 and Total Capital is -0.16. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 17.81 points at the first support level, and at 16.34 for the second support level. However, for the 1st resistance point, the stock is sitting at 20.04, and for the 2nd resistance point, it is at 20.80.
Ratios To Look Out For
It’s worth pointing out that Cg Oncology Inc [NASDAQ:CGON]’s Current Ratio is 35.30. Further, the Quick Ratio stands at 35.30, while the Cash Ratio is 12.03. Considering the valuation of this stock, the price to sales ratio is 1289.05, the price to book ratio is 2.00.
Transactions by insiders
Recent insider trading involved POST LEONARD E, Director, that happened on Mar 17 ’25 when 1000.0 shares were sold. Director, LEONARD E POST completed a deal on Mar 17 ’25 to buy 4000.0 shares. Meanwhile, Director POST LEONARD E sold 1000.0 shares on Feb 18 ’25.
